Natco Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has submitted a regulatory certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine compliance filing, typically submitted annually by listed companies to confirm adherence to depository-related rules concerning the holding and transfer of shares in dematerialised form. No specific financial numbers, operational updates, or material disclosures were provided in this filing.
This is a standard regulatory formality with no direct impact on the company's financials, business operations, or stock price. It mainly signals ongoing compliance with SEBI's depository regulations.